Who founded Enumera Molecular?

Enumera Molecular was founded by Matthew Cooper in 2022.

Who are Enumera Molecular's investors?

Enumera Molecular's investors include Arboretum Ventures.

How much funding has Enumera Molecular raised?

Enumera Molecular has disclosed $31M raised across 2 rounds.

Where is Enumera Molecular headquartered?

Enumera Molecular is headquartered in Ann Arbor, US.

Enumera Molecular

Ann Arbor, US · Founded 2022 · Delaware corporation · 16 employees on LinkedIn · 1 known investors

Find your way into Enumera Molecular

355 people in our graph share verified history with the Enumera Molecular team — schools, employers, funds. One of them is your warm intro.

Yibo Nianunlockedknows Matthew Cooper · together at Columbia Business School (overlapped)

knows the team · via University of California, Berkeley, Haas School of Business

×2knows the team · via Columbia Business School

×8knows the team · via StartX

Enumera Molecular develops technology and a platform for simplified, lower-cost workflows that enable liquid biopsy and high-dimensional omics assays for laboratories. It targets clinical labs performing molecular diagnostics.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Enumera Molecular was founded in 2022 by Matthew Cooper.

Matthew Cooper inFounder · Chief Executive OfficerMatthew Cooper holds a Ph.D. in Toxicology from the University of Kentucky and dual MBAs from Columbia Business School and UC Berkeley Haas School of Business. He has over 20 years of experience in diagnostic and data science product development, with expertise in biomarker discovery, bioinformatics, and drug development, and previously founded multiple biotech and diagnostic companies.

Elaine HeronNamed on SEC filing

Board

Dan Kidle inBoard MemberManaging Partner at Arboretum Ventures

Sundaresh BrahmasandraBoard director

Investors · 1

Arboretum VenturesAnn Arbor · $5M – $15M

Reported raises · per SEC filings

Form D private placements

$31M disclosed across 2 rounds · 2022–2026

▶$12.3MraisedJul 2026 · 12 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Matthew CooperExecutive Officer, Director
Dan KidleDirector
Elaine HeronDirector
Sundaresh BrahmasandraDirector

Offering amount: $17.4M
Amount sold: $12.3M
First sale: Jul 2026
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$18.7MraisedAug 2022 · 5 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Matthew CooperExecutive Officer, Director

Offering amount: $19M
Amount sold: $18.7M
First sale: May 2022
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

IDbyDNA4 shared keywordsScalable, high throughput DNA sequencing platforms.

Genomenon3 shared keywordsGenomenon uses AI to read biomedical literature and expert scientists to curate variant- and patient-level genomic evidence, delivering regulatory-grade real-world evidence. Its products, including Mastermind and CKB, serve drug development teams and clinical genetic testing labs for variant interpretation and drug program decisions.

Invitae3 shared keywordsInvitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life. Now part of Labcorp, the company leverages a nationwide network of patient service centers and coverage by most health plans to make genetic testing more accessible.

Companies competing with Enumera Molecular for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Ann Arbor Michigan based Enumera Molecular is raising $18,970,000.00 in New Equity Investment. - intelligence360intelligence360.news · Sep 2022

Enumera Molecular Acquires Progenity Liquid Biopsy Tech, Raises $12.5M in Series A Round | Arboretum Venturesarboretumvc.com · May 2022

Frequently asked questions

What does Enumera Molecular do?: Enumera Molecular develops technology and a platform for simplified, lower-cost workflows that enable liquid biopsy and high-dimensional omics assays for laboratories. It targets clinical labs performing molecular diagnostics.
Who founded Enumera Molecular?: Enumera Molecular was founded by Matthew Cooper in 2022.
Who are Enumera Molecular's investors?: Enumera Molecular's investors include Arboretum Ventures.
How much funding has Enumera Molecular raised?: Enumera Molecular has disclosed $31M raised across 2 rounds.
Where is Enumera Molecular headquartered?: Enumera Molecular is headquartered in Ann Arbor, US.